These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 24718102)

  • 1. Proteins recruited to exosomes by tau overexpression implicate novel cellular mechanisms linking tau secretion with Alzheimer's disease.
    Saman S; Lee NC; Inoyo I; Jin J; Li Z; Doyle T; McKee AC; Hall GF
    J Alzheimers Dis; 2014; 40 Suppl 1(Suppl 1):S47-70. PubMed ID: 24718102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. mTor mediates tau localization and secretion: Implication for Alzheimer's disease.
    Tang Z; Ioja E; Bereczki E; Hultenby K; Li C; Guan Z; Winblad B; Pei JJ
    Biochim Biophys Acta; 2015 Jul; 1853(7):1646-57. PubMed ID: 25791428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomal and vesicle-free tau seeds-propagation and convergence in endolysosomal permeabilization.
    Polanco JC; Götz J
    FEBS J; 2022 Nov; 289(22):6891-6907. PubMed ID: 34092031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fate and propagation of endogenously formed Tau aggregates in neuronal cells.
    Chastagner P; Loria F; Vargas JY; Tois J; I Diamond M; Okafo G; Brou C; Zurzolo C
    EMBO Mol Med; 2020 Dec; 12(12):e12025. PubMed ID: 33179866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysregulation of Exosome Cargo by Mutant Tau Expressed in Human-induced Pluripotent Stem Cell (iPSC) Neurons Revealed by Proteomics Analyses.
    Podvin S; Jones A; Liu Q; Aulston B; Ransom L; Ames J; Shen G; Lietz CB; Jiang Z; O'Donoghue AJ; Winston C; Ikezu T; Rissman RA; Yuan S; Hook V
    Mol Cell Proteomics; 2020 Jun; 19(6):1017-1034. PubMed ID: 32295833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel human neuronal tau model exhibiting neurofibrillary tangles and transcellular propagation.
    Reilly P; Winston CN; Baron KR; Trejo M; Rockenstein EM; Akers JC; Kfoury N; Diamond M; Masliah E; Rissman RA; Yuan SH
    Neurobiol Dis; 2017 Oct; 106():222-234. PubMed ID: 28610892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sources of extracellular tau and its signaling.
    Avila J; Simón D; Díaz-Hernández M; Pintor J; Hernández F
    J Alzheimers Dis; 2014; 40 Suppl 1():S7-S15. PubMed ID: 24531154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimalistic in vitro systems for investigating tau pathology.
    Hallinan GI; Pitera AP; Patel P; West J; Deinhardt K
    J Neurosci Methods; 2019 May; 319():69-76. PubMed ID: 30278185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of tau self-aggregation and neurotoxicity.
    Farías G; Cornejo A; Jiménez J; Guzmán L; Maccioni RB
    Curr Alzheimer Res; 2011 Sep; 8(6):608-14. PubMed ID: 21605046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assembly of filamentous tau aggregates in human neuronal cells.
    Ko LW; Rush T; Sahara N; Kersh JS; Easson C; Deture M; Lin WL; Connor YD; Yen SH
    J Alzheimers Dis; 2004 Dec; 6(6):605-22; discussion 673-81. PubMed ID: 15665401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A NH2 tau fragment targets neuronal mitochondria at AD synapses: possible implications for neurodegeneration.
    Amadoro G; Corsetti V; Stringaro A; Colone M; D'Aguanno S; Meli G; Ciotti M; Sancesario G; Cattaneo A; Bussani R; Mercanti D; Calissano P
    J Alzheimers Dis; 2010; 21(2):445-70. PubMed ID: 20571215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain Exosomes: Friend or Foe in Alzheimer's Disease?
    Kaur S; Verma H; Dhiman M; Tell G; Gigli GL; Janes F; Mantha AK
    Mol Neurobiol; 2021 Dec; 58(12):6610-6624. PubMed ID: 34595669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-in-Rat Study of Human Alzheimer's Disease Tau Propagation.
    Smolek T; Jadhav S; Brezovakova V; Cubinkova V; Valachova B; Novak P; Zilka N
    Mol Neurobiol; 2019 Jan; 56(1):621-631. PubMed ID: 29770957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tau Secretion.
    Ruan Z; Ikezu T
    Adv Exp Med Biol; 2019; 1184():123-134. PubMed ID: 32096034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel drugs affecting tau behavior in the treatment of Alzheimer's disease and tauopathies.
    Navarrete LP; Pérez P; Morales I; Maccioni RB
    Curr Alzheimer Res; 2011 Sep; 8(6):678-85. PubMed ID: 21605038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are tangles as toxic as they look?
    Spires-Jones TL; Kopeikina KJ; Koffie RM; de Calignon A; Hyman BT
    J Mol Neurosci; 2011 Nov; 45(3):438-44. PubMed ID: 21638071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AMPK is abnormally activated in tangle- and pre-tangle-bearing neurons in Alzheimer's disease and other tauopathies.
    Vingtdeux V; Davies P; Dickson DW; Marambaud P
    Acta Neuropathol; 2011 Mar; 121(3):337-49. PubMed ID: 20957377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tau accumulation causes mitochondrial distribution deficits in neurons in a mouse model of tauopathy and in human Alzheimer's disease brain.
    Kopeikina KJ; Carlson GA; Pitstick R; Ludvigson AE; Peters A; Luebke JI; Koffie RM; Frosch MP; Hyman BT; Spires-Jones TL
    Am J Pathol; 2011 Oct; 179(4):2071-82. PubMed ID: 21854751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spreading of tau pathology in Alzheimer's disease by cell-to-cell transmission.
    Mohamed NV; Herrou T; Plouffe V; Piperno N; Leclerc N
    Eur J Neurosci; 2013 Jun; 37(12):1939-48. PubMed ID: 23773063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression of Alzheimer's disease, tau propagation, and its modifiable risk factors.
    Takeda S
    Neurosci Res; 2019 Apr; 141():36-42. PubMed ID: 30120962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.